Sign in to view content

Dropless Vitrectomy Surgery for Dense Vitreous Hemorrhage Secondary to Proliferative Diabetic Retinopathy; Efficacy and Safety Compared With Standard of Care

K. V. Chalam, MD, PhD, MBA, FRCS(C), FASRS

Video
Published 2024

Related

Effect of 6 month anti-VEGF treatment for proliferative diabetic retinopathy on the quantitative metrics of the retinal microvasculature on OCTA
Quan V. Hoang, MD, PhD
On Demand Cases, Courses, and Papers
2019
Endolaserless Vitrectomy with Intravitreal Aflibercept
Dennis M. Marcus, MD
Updates from the Field
2017
Current United States Treatment Patterns for the Treatment of Proliferative Diabetic Retinopathy in the IRIS Registry
Jeremiah Brown, MD, MS, FASRS
Annual Meeting Talks
2020

Category: Pharmacology

See more